MiniMed names Medtronic executive Scott Cundy to board, effective July 3

• MiniMed disclosed a board change, with Class II director Brett Wall set to resign effective July 3, 2026.
• The departure follows Wall’s exit as executive vice president and president of Medtronic’s Neuroscience Portfolio, which had nominated him to the board.
• Scott Cundy was appointed to the board effective July 3, 2026, filling the vacancy.
• Cundy is Medtronic’s senior vice president and chief quality, development, and innovation officer, leading global quality, product development, and innovation functions.
• He previously served at Danaher as vice president of quality, regulatory, and clinical affairs for diagnostics and life sciences platforms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MiniMed Group Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-063267), on May 18, 2026, and is solely responsible for the information contained therein.